Document is current
Any future updates will be listed below
-
Authors
Harada, Miyuki
Kimura, Fuminori
Takai, Yasushi
Nakajima, Takeshi
Ushijima, Kimio
Kobayashi, Hiroaki
Satoh, Toyomi
Tozawa, Akiko
Sugimoto, Kohei
Saji, Shigehira
Shimizu, Chikako
Akiyama, Kyoko
Bando, Hiroko
Kuwahara, Akira
Furui, Tatsuro
Okada, Hiroshi
Kawai, Koji
Shinohara, Nobuo
Nagao, Koichi
Kitajima, Michio
Suenobu, Souichi
Soejima, Toshinori
Miyachi, Mitsuru
Miyoshi, Yoko
Yoneda, Akihiro
Horie, Akihito
Ishida, Yasushi
Usui, Noriko
Kanda, Yoshinobu
Fujii, Nobuharu
Endo, Makoto
Nakayama, Robert
Hoshi, Manabu
Yonemoto, Tsukasa
Kiyotani, Chikako
Okita, Natsuko
Baba, Eishi
Muto, Manabu
Kikuchi, Iwaho
Morishige, Ken-ichirou
Tsugawa, Koichiro
Nishiyama, Hiroyuki
Hosoi, Hajime
Tanimoto, Mitsune
Kawai, Akira
Sugiyama, Kazuhiko
Boku, Narikazu
Yonemura, Masato
Hayashi, Naoko
Aoki, Daisuke
Osuga, Yutaka
Suzuki, Nao https://orcid.org/0000-0002-7440-8127
- License Information
-
More Information
Article History
Received: 25 October 2021
Accepted: 7 November 2021
First Online: 1 January 2022
Declarations
:
: All members of the Guideline Working Committee behaved in accordance with the JSCO Guidelines for Conflicts of Interest Issues Related to Clinical Studies of Oncology. Potential conflicts of interest of individual committee members are declared at . Development of these JSCO Guidelines was entirely funded by the JSCO. Neither the opinions nor the interests of the funding body (JSCO) affected the final guideline recommendations.
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and its later versions. This article does not refer to any studies in humans or animals performed by any of the authors.
